@ Chimerix files for $85M public stock offering | SEBIO

Chimerix files for $85M public stock offering

Posted by on Mar 12, 2013

DURHAM, NC – Antiviral developer Chimerix says it has filed for an initial public offering.

Chimerix aims to raise up to $85 million in the offering. The company, which booked $34 million in revenue in 2012, plans to trade under the symbol CMRX on Nasdaq.

A registration statement has been filed but hasn’t become effective, the company says.

Morgan Stanley and Cowen and Company are acting as joint book-running managers, and William Blair and Lazard Capital Markets LLC are co-managers.

For more on how Chimerix is moving ahead with its antiviral candidates, click here.


Leave a Reply